Roka Bioscience to Co-Present Industry Webinar

WARREN, N.J., June 26, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens will host and present, along with Primus Laboratories, an informative webcast titled "Food Safety Pixels to Pictures: How to Bring your Data to Life".

This webcast topics will include:

• The importance of higher quality individual results and how accuracy of these result serves as the foundation of your entire food safety program 
• Assembling the food safety picture through software to achieve the best ROI from your food safety investments and programs
• Applying software in real world settings - A Case Study
• Bringing the picture together with granular data to achieve better supply chain control

This free webcast will take place live on Wednesday, June 28^th at 2:00 PM EDT.

The webcast speakers will include Dr. Erin Dreyling, Vice President of Research and Scientific Affairs at Roka Bioscience, who will discuss how making the jump to molecular technology can elevate a pathogen control program. She will also discuss the evolution of molecular technology in food testing and how the old mores no longer apply. "Your data is only as good as the inputs that go into it. Inaccurate data allows pathogen control programs to be built on shaky foundations," said Dr. Dreyling.

The Webcast will also include Joseph Myers, Director of the PrimusLabs Training Center, who will provide a step-by-step overview of how combining new software solutions with a holistic approach enable companies to bring multiple data points together to enable faster, more confident product release and mitigation decisions. Also presenting from Primus-Azzule is Jon Takahashi who will specifically address applying these concepts to the ever-growing complexity in supply chain management and control. Join us for this informative webinar. Don't miss out, register today.

About PrimusLabs

For 30 years, PrimusLabs has remained the single point of contact in food safety for microbiological and pesticide residue testing, data management/analytics, consulting, and audit scheme ownership. PrimusLabs utilizes state-of-the-art technology, degreed technical staff, and QA oversight to raise your results to an actionable level. Visit http://www.PrimusLabs.com for more information.

Azzule Systems provides data management solutions for today's complex supply chains. Providing different methods of data input, data storage and data movement, Azzule Systems assists in meeting the diverse demands of their customers, including food retailers, the food service industry, distributors and retailers. Whether it's food safety data, sustainability data or any other form of valuable information, Azzule Systems can provide for your organization. For more information, visit http://www.azzule.com today.

About Roka Bioscience 
Roka Bioscience, Inc. is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas^® Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit http://www.rokabio.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act, as amended (the "Exchange Act"), including those related to our planned service offerings. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions. Any statements contained herein (including, without limitation, statements to the effect that we "believe", "expect", "anticipate", "plan" and similar expressions) that are not statements of historical fact should be considered forward-looking statements. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward looking statements. There are a number of important factors that could cause actual results to differ materially from those indicated by such forward-looking statements. Such factors include those set forth in the company's filings with the Securities and Exchange Commission. We expressly disclaim any obligation to update any forward-looking statements, except as may be required by law.  Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements represent our estimates and assumptions only as of the date of this press release and, except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

Investor or Media related inquiries please contact:

Investor Contact: 
Roka Bioscience, Inc. 
[email protected] 
855-ROKABIO (855-765-2246)

SOURCE Roka Bioscience, Inc.

Related Links

http://www.rokabio.com